Process for the preparation of Enzalutamide

US10131636B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10131636-B2
Application numberUS-201515516206-A
CountryUS
Kind codeB2
Filing dateOct 1, 2015
Priority dateOct 1, 2014
Publication dateNov 20, 2018
Grant dateNov 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to an improved process for the preparation of enzalutamide by conventional synthesis, which avoids utilization of microwave irradiation and noxious reagents. The present invention also relates to an improved process for preparation of 4-isothiocyanato-2-(trifluoromethyl) benzonitrile, which is an intermediate in the synthesis of Enzalutamide.

First claim

Opening claim text (preview).

We claim: 1. A process for the preparation of enzalutamide of Formula I, comprising: a) reacting 4-amino-2-trifluoromethyl benzonitrile of Formula 2 with a source of isothiocyanate of Formula P-NCS, to obtain a compound of Formula 8, wherein ‘P’ represents hydrogen or a protective group, b) optionally deprotecting the compound of Formula 8 to obtain a compound of Formula 9, c) heating the compound of Formula 9 to obtain a compound of Formula 3, d) reacting the compound of Formula 3 with a compound of Formula 4 in a solvent system to obtain a compound of Formula 5, and e) reacting the compound of Formula 5 with an acid in an organic solvent to obtain enzalutamide. 2. The process of claim 1 , wherein the protective group is selected from one of R—CO—, R—CO—O—, and R—SO 2 —, and wherein ‘R’ is selected from one of an alkyl, an alkoxy, a haloalkyl, an aryl, an aralkyl and an aryloxy. 3. The process of claim 1 , wherein ‘P’ is the protective group benzoyl. 4. The process of claim 1 , wherein the source of isothiocyanate is benzoyl isothiocyanate. 5. The process of claim 1 , wherein the step a) is carried out in the presence of a solvent. 6. The process of claim 5 , wherein the solvent of the step a) is selected from one of acetone, methyl tertiary butyl ether, and tetrahydrofuran. 7. The process of claim 1 , wherein the deprotection is carried out in the presence of a base. 8. The process of claim 7 , wherein the base is selected from one of sodium hydroxide and potassium hydroxide. 9. The process of claim 1 , wherein the step c) is carried out in a solvent selected from one of toluene, chlorobenzene, bromo benzene, ethyl benzene, xylenes, cumene, trimethylbenzene and mixtures thereof. 10. The process of claim 1 , wherein the step c) of heating is carried out at a temperature of about 100° C. to 150° C. 11. The process of claim 1 , wherein the step c) is carried out at a temperature of about 130-135° C. in chlorobenzene. 12. The process of claim 1 , wherein the solvent of step d) is selected from one of an amide, a nitrile, an ether, an ester, a sulfone, and mixtures thereof. 13. The process of claim 1 , wherein the solvent of the step d) is selected from one of dimethyl formamide, dimethyl sulfoxide, tetrahydrofuran, and mixtures thereof. 14. The process of claim 1 , wherein the step d) is carried out under stirring at a temperature of about 50° C. to 90° C. 15. The process of claim 1 , wherein the acid is selected from one of hydrochloric acid, hydrobromic acid, sulfuric acid, perchloric acid, phosphoric acid, acetic acid, trifluoro acetic acid, trichloro acetic acid, methane sulfonic acid, and mixtures thereof. 16. The process of claim 1 , wherein the organic solvent is selected from one of an alcohol, a halogenated hydrocarbon, an aromatic hydrocarbon, and mixtures thereof. 17. The process of claim 1 , wherein the acid is hydrochloric acid and the organic solvent is methanol. 18. The process according to claim 1 , further comprising: f) combining the enzalutamide with at least one pharmaceutically acceptable excipient.

Assignees

Inventors

Classifications

  • C07D233/86Primary

    Oxygen and sulfur atoms, e.g. thiohydantoin · CPC title

  • Y being a hydrogen or a carbon atom, e.g. benzoylthioureas · CPC title

  • being further substituted by carboxyl groups · CPC title

  • having nitrogen atoms of thiocarbamic groups bound to carbon atoms of six-membered aromatic rings · CPC title

  • having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10131636B2 cover?
The present invention relates to an improved process for the preparation of enzalutamide by conventional synthesis, which avoids utilization of microwave irradiation and noxious reagents. The present invention also relates to an improved process for preparation of 4-isothiocyanato-2-(trifluoromethyl) benzonitrile, which is an intermediate in the synthesis of Enzalutamide.
Who is the assignee on this patent?
Laurus Labs Ltd, Laurus Labs Ltd
What technology area does this patent fall under?
Primary CPC classification C07D233/86. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).